BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7695333)

  • 1. Chemoprophylaxis of Cryptosporidium parvum infection with paromomycin in kids and immunological study.
    Mancassola R; Reperant JM; Naciri M; Chartier C
    Antimicrob Agents Chemother; 1995 Jan; 39(1):75-8. PubMed ID: 7695333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
    Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
    Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectivity of Cryptosporidium parvum isolated from asymptomatic adult goats to mice and goat kids.
    Noordeen F; Horadagoda NU; Faizal AC; Rajapakse RP; Razak MA; Arulkanthan A
    Vet Parasitol; 2002 Jan; 103(3):217-25. PubMed ID: 11750115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of innate immunity in newborn kids against Cryptosporidium parvum infection-challenge by intranasal/per-oral administration of liposomal formulation of N-L18-norAbu-GMDP adjuvant.
    Turánek J; Kasná A; Koudela B; Ledvina M; Miller AD
    Parasitology; 2005 Nov; 131(Pt 5):601-8. PubMed ID: 16255818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA.
    Sagodira S; Buzoni-Gatel D; Iochmann S; Naciri M; Bout D
    Vaccine; 1999 May; 17(19):2346-55. PubMed ID: 10392616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cotrimoxazole on experimental Cryptosporidium parvum infection in kids.
    Koudela B; Boková A
    Vet Res; 1997; 28(4):405-12. PubMed ID: 9257448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum.
    Healey MC; Yang S; Rasmussen KR; Jackson MK; Du C
    J Parasitol; 1995 Feb; 81(1):114-6. PubMed ID: 7876965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of anticryptosporidial activity of paromomycin with that of other aminoglycosides and azithromycin in immunosuppressed rats.
    Rehg JE
    J Infect Dis; 1994 Oct; 170(4):934-8. PubMed ID: 7930738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.
    Jenkins MC; O'Brien C; Trout J; Guidry A; Fayer R
    Vaccine; 1999 May; 17(19):2453-60. PubMed ID: 10392628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent response to challenge infection with Cryptosporidium parvum in immunosuppressed C57BL/6N mice.
    Surl CG; Kim HC
    J Vet Sci; 2006 Mar; 7(1):47-51. PubMed ID: 16434849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the prophylactic and therapeutic effects of paromomycin, recombinant IL-12 alone or in combination against Cryptosporidium parvum infection in immunosuppressed mice.
    Gamra MM; el-Hosseiny LM
    J Egypt Soc Parasitol; 2003 Apr; 33(1):109-22. PubMed ID: 12739805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of curative anticryptosporidial activity of paromomycin in a dexamethasone-treated rat model.
    Verdon R; Polianski J; Gaudebout C; Marche C; Garry L; Pocidalo JJ
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1681-2. PubMed ID: 7979310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time gap between oocyst shedding and antibody responses in mice infected with Cryptosporidium parvum.
    Yu JR; Lee SU
    Korean J Parasitol; 2007 Sep; 45(3):225-8. PubMed ID: 17876169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of decoquinate to treat experimental cryptosporidiosis in kids.
    Mancassola R; Richard A; Naciri M
    Vet Parasitol; 1997 Apr; 69(1-2):31-7. PubMed ID: 9187027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of halofuginone lactate against experimental cryptosporidiosis in goat neonates.
    Petermann J; Paraud C; Pors I; Chartier C
    Vet Parasitol; 2014 May; 202(3-4):326-9. PubMed ID: 24636788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field trial on the therapeutic efficacy of paromomycin on natural Cryptosporidium parvum infections in lambs.
    Viu M; Quílez J; Sánchez-Acedo C; del Cacho E; López-Bernad F
    Vet Parasitol; 2000 Jun; 90(3):163-70. PubMed ID: 10841996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of calves against cryptosporiosis by oral inoculation with gamma-irradiated Cryptosporidium parvum oocysts.
    Jenkins M; Higgins J; Kniel K; Trout J; Fayer R
    J Parasitol; 2004 Oct; 90(5):1178-80. PubMed ID: 15562625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptosporidium parvum in calves: kinetics and immunoblot analysis of specific serum and local antibody responses (immunoglobulin A [IgA], IgG, and IgM) after natural and experimental infections.
    Peeters JE; Villacorta I; Vanopdenbosch E; Vandergheynst D; Naciri M; Ares-Mazás E; Yvoré P
    Infect Immun; 1992 Jun; 60(6):2309-16. PubMed ID: 1587597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.